Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

16 Aug 2012 11:29

RNS Number : 1678K
Oryx International Growth Fund Ld
16 August 2012
 

ORYX INTERNATIONAL GROWTH FUND LIMITED

 INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 30 JUNE 2012

 Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 This interim management statement relates to the period from 1 April 2012 to 30 June 2012, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 Manager's Review

During the period under review, the FTSE Small Cap TR (£) Index returned -4.24% and the FTSE All-Share TR Index (£) returned -2.63%. Against this, the Fund's net asset value decreased by 4.5% to 292p per share.

 The Manager anticipates that a number of the holdings within the Company's portfolio will benefit from corporate activity during the next twelve months.

 Material Transactions

Since 1 April 2012, the Company has purchased for cancellation the following shares:

 24 April 2012 a total of 379,653 ordinary shares at a gross price of £2.10 per share.

Material Events

There were no material events during the quarter ended 30 June 2012.

 Report and Accounts

On 15 June 2012, the Company posted its Annual Report and Accounts for the year ended 31 March 2012, to Shareholders.

Financial Highlights

 

 

30 June 2012 

31 March 2012 

31 December 2011 

30 September 2011 

30 June 2011 

 

 

 

 

 

 

NAV

£2.93

£3.03

£2.79

£2.69

£2.96

 

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5685

 

1.5978

 

1.5541

 

1.5579

 

1.6055

 

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 30 June 2012

 

% Net Assets

Cvs Group Plc

7.85

Bioquell Plc

6.84

Gleeson (M.J.) Group Plc

6.67

Guinness Peat Group Plc

6.36

Orthoproducts Ltd

4.99

Augean Plc

4.96

Journey Group Plc

4.29

Eckoh Plc

4.28

Quarto Group Inc

4.26

Catalyst Media Group Plc

4.14

Assetco Plc

3.80

Innovation Group Plc

3.76

Sinclair Is Pharma Plc

3.23

Rpc Group Plc

2.75

Nastor Inv Ltd Zero Redeem Prefer Shares

2.61

Mecom Group Plc

2.42

Bionostics Holdings Ltd

2.40

Celsis Ag

2.09

Bavaria Industriekapital Ag

2.09

Sinav Limited

1.99

81.78

 

 

The financial information for the quarter ended 30 June 2012 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUCPRUPPGUQ
Date   Source Headline
27th Jul 20126:00 pmRNSNet Asset Value(s)
25th Jul 20122:32 pmRNSResult of AGM
29th Jun 20129:45 amRNSChange of Adviser
28th Jun 20125:35 pmRNSHolding(s) in Company
28th Jun 201212:00 pmRNSNet Asset Value(s)
21st Jun 20127:00 amRNSAnnual Report and Accounts and Notice of AGM
20th Jun 20124:40 pmRNSSecond Price Monitoring Extn
20th Jun 20124:35 pmRNSPrice Monitoring Extension
15th Jun 20127:00 amRNSFinal Results
24th May 20125:00 pmRNSNet Asset Value(s)
11th May 20129:34 amRNSHolding(s) in Company
27th Apr 20126:00 pmRNSNet Asset Value(s)
25th Apr 20125:05 pmRNSHolding(s) in Company
24th Apr 201211:10 amRNSTransaction in Own Shares
17th Apr 20121:09 pmRNSListing Rule 15.5.1(4)
12th Apr 20128:38 amRNSHolding(s) in Company
23rd Mar 201210:04 amRNSHolding(s) in Company
20th Mar 20126:03 pmRNSNet Asset Value(s)
5th Mar 20123:18 pmRNSHolding(s) in Company
27th Feb 201212:04 pmRNSHolding(s) in Company
21st Feb 20124:33 pmRNSNet Asset Value(s)
17th Feb 20125:30 pmRNSTransaction in Own Shares
17th Feb 20129:31 amRNSInterim Management Statement
9th Feb 201210:52 amRNSTransaction in Own Shares
23rd Jan 20124:30 pmRNSNet Asset Value(s)
28th Dec 20114:00 pmRNSTransaction in Own Shares
21st Dec 20114:15 pmRNSNet Asset Value(s)
19th Dec 20113:30 pmRNSTransaction in Own Shares
14th Dec 201111:00 amRNSTransaction in Own Shares
30th Nov 20114:55 pmRNSNet Asset Value(s)
28th Nov 20117:00 amRNSChange of Name of Investment Manager
25th Nov 20114:23 pmRNSHalf Yearly Report
24th Nov 201110:03 amRNSHolding(s) in Company
31st Oct 20116:00 pmRNSNet Asset Value(s)
27th Oct 20111:00 pmRNSNotification of Major Interest in Shares
19th Oct 201110:42 amRNSListing Rule 15.5.1(4)
27th Sep 201112:00 pmRNSNet Asset Value(s)
26th Sep 20118:49 amRNSNotice of Interest in Shares
26th Aug 20114:00 pmRNSNet Asset Value(s)
8th Aug 201111:45 amRNSInterim Management Statement
22nd Jul 20115:00 pmRNSNet Asset Value(s)
14th Jul 20112:13 pmRNSAnnual Report and Accounts and Notice of AGM
8th Jul 201110:56 amRNSAnnual Information Update
30th Jun 20116:00 pmRNSAnnual Financial Report
20th Jun 20115:30 pmRNSNet Asset Value(s)
16th Jun 201112:35 pmRNSHolding(s) in Company
16th Jun 20119:23 amRNSHolding(s) in Company
14th Jun 20117:00 amRNSHolding(s) in Company
6th Jun 20114:52 pmRNSHolding(s) in Company
3rd Jun 20115:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.